A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease

• Jeremy D. Baker,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Validation, Writing – review & editing

  Affiliations Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, WA, United States of America, Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, United States of America

  ⨯
• Rikki L. Uhrich,

  Roles Formal analysis, Investigation, Methodology, Writing – review & editing

  Affiliation Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, United States of America

  ⨯
• Gerald C. Kraemer,

  Roles Software, Validation, Writing – review & editing

  Affiliation Thomas Jefferson High School, Auburn, WA, United States of America

  ⨯
• Jason E. Love,

  Roles Validation, Writing – review & editing

  Affiliation Western Washington Pathology, Tacoma, WA, United States of America

  ⨯
• Brian C. Kraemer

  Roles Conceptualization, Data curation, Funding acquisition, Methodology, Project administration, Resources, Software, Supervision, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: kraemerb@uw.edu

  Affiliations Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, WA, United States of America, Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, United States of America, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States of America, Department of Pathology, University of Washington, Seattle, WA, United States of America

  https://orcid.org/0000-0002-2252-7634

  ⨯